Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Myelodysplastic Syndromes 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Hematologic Neoplasms 3Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Graft vs Host Disease 2Ganglioneuroblastoma 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Teratoma 1Recurrence 1Neuroblastoma 1Multiple Myeloma 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Mast-Cell 1Leukemia, Large Granular Lymphocytic 1Leukemia 1High Risk Myeloid Malignancies 1GATA2 Deficiency 1Choriocarcinoma 1Carcinoma, Embryonal 1

Interventions

Magnetic Resonance Spectroscopy 9Specimen Handling 7X-Rays 6Phantoms, Imaging 6Nuclear Medicine Department, Hospital 5Temozolomide 4Biopsy 4Vincristine 3Cyclophosphamide 3Cisplatin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2pembrolizumab 2palbociclib 2olaparib 2lutetium Lu 177 dotatate 2larotrectinib 2ivosidenib 2erdafitinib 2ensartinib 2Radiotherapy 2Radiation 2Platinum 2Lomustine 2LY3023414 2Diphtheria-Tetanus Vaccine 21,2-diaminocyclohexaneplatinum II citrate 2sodium thiosulfate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Medulloblastoma × Thiotepa × 90 days × Clear all
NCT02875314 2026-06-03

HeadStart4: Newly Diagnosed Children (<10 y/o) With Medulloblastoma and Other CNS Embryonal Tumors

Nationwide Children's Hospital

Phase 4 Active not recruiting
250 enrolled
CNS

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡